Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, Alejandro Salah & Sally Nelson. (2023) Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics 0:0, pages 1-8.
Read now
Read now
Articles from other publishers (59)
Hesham A. Abou-Zied, Eman A.M. Beshr, Alaa M. Hayallah & Mohamed Abdel-Aziz. (2024) Emerging insights into pyrazoline motifs: A comprehensive exploration of biological mechanisms and prospects for future advancements. Journal of Molecular Structure 1296, pages 136807.
Crossref
Crossref
Venkatesan Santhanam, Priya Modi, Umesh K. Mishra, Ishrat Jahan, Namakkal G. Ramesh & Shashank Deep. (2023) Rational design and synthesis of novel triazole- and tetrazole-fused iminosugars as potential inhibitors of amyotrophic lateral sclerosis (ALS) linked SOD1 aggregation. International Journal of Biological Macromolecules 253, pages 126900.
Crossref
Crossref
Marwa Atallah, Toru Yamashita, Xiao Hu, Xinran Hu & Koji Abe. (2023) Edaravone Confers Neuroprotective, Anti-inflammatory, and Antioxidant Effects on the Fetal Brain of a Placental-ischemia Mouse Model. Journal of Neuroimmune Pharmacology.
Crossref
Crossref
Francesca Provenzano, Carola Torazza, Tiziana Bonifacino, Giambattista Bonanno & Marco Milanese. (2023) The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity. International Journal of Molecular Sciences 24:20, pages 15430.
Crossref
Crossref
Jiawei Zhang, Yining Xiao, Hongna Liu, Lili Xu, Xing Guo, Yaran Gao, Meixi Li, Jing Xu, Qianqian Qi & Peiyuan Lv. (2023) Edaravone Dexborneol Alleviates Neuroinflammation by Reducing Neuroglial Cell Proliferation and Suppresses Neuronal Apoptosis/Autophagy in Vascular Dementia Rats. Neurochemical Research 48:10, pages 3113-3128.
Crossref
Crossref
Ruizhi Lai, Shuran Xu, Qingyao Zhang, Hui Zhou, Cankun Luo, Yuerong Wang, Li Hai & Yong Wu. (2023) Derivation of Benzothiadiazine‐1,1‐dioxide Scaffolds via Transition Metal‐Catalyzed C—H Activation/Annulation. Chinese Journal of Chemistry 41:16, pages 1973-1978.
Crossref
Crossref
Katarzyna Ciećwierska, Dorothée Lulé, Olga Helczyk, Krzysztof Nieporęcki, Maksymilian Bielecki, Susanne Baader, Albert C. Ludolph & Magdalena Kuźma-Kozakiewicz. (2023) Religiosity in patients with amyotrophic lateral sclerosis, a cross-country comparison. Quality of Life Research 32:8, pages 2235-2246.
Crossref
Crossref
Sankha Bhattacharya. (2023) Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of
Dementia Patients. Current Pharmaceutical Biotechnology 24:9, pages 1108-1121.
Crossref
Crossref
Yuan Lu, Julie Tzu-Wen Wang, Na Li, Xiaoqin Zhu, Yongjun Li, Sukhi Bansal, Yonglin Wang & Khuloud T. Al-Jamal. (2023) Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability. Journal of Controlled Release 359, pages 257-267.
Crossref
Crossref
Wan Zheng, Tianfa Li, Junping Wei, Yani Yan & Shanshan Yang. (2023) Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression. The Korean Journal of Physiology & Pharmacology 27:3, pages 209-220.
Crossref
Crossref
Emad H.M. Hassanein, Wafaa R. Mohamed, Rasha M. Hussein & El-Shaimaa A. Arafa. (2023) Edaravone alleviates methotrexate-induced testicular injury in rats: Implications on inflammation, steroidogenesis, and Akt/p53 signaling. International Immunopharmacology 117, pages 109969.
Crossref
Crossref
O.A. Halushko. (2023) Edaravone in the treatment of concussion and post-concussion syndrome. Infusion & Chemotherapy:1, pages 32-37.
Crossref
Crossref
Qianqian Zhang, Qingyang Li, Huihui Zhao, Mingzhu Shu, Maotao Luo, Yanan Li, Yu Ding, Shiyu Shi, Xi Cheng & Qi Niu. (2023) Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study. Frontiers in Neurology 14.
Crossref
Crossref
Yuanyuan Shen, Ji Zhang, Yiluo Xu, Shuneng Sun, Kaili Chen, Siping Chen, Xifei Yang & Xin Chen. (2023) Ultrasound–enhanced brain delivery of edaravone provides additive amelioration on disease progression in an ALS mouse model. Brain Stimulation 16:2, pages 628-641.
Crossref
Crossref
Marc Gotkine, Yoseph Caraco, Yossef Lerner, Simcha Blotnick, Maor Wanounou, Shalom Guy Slutsky, Judith Chebath, Graciela Kuperstein, Elena Estrin, Tamir Ben-Hur, Arik Hasson, Kfir Molakandov, Tehila Sonnenfeld, Yafit Stark, Ariel Revel, Michel Revel & Michal Izrael. (2023) Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results. Journal of Translational Medicine 21:1.
Crossref
Crossref
Purushottam Neupane, Pawan Kumar Thada, Pramod Singh, Abdul Rafae Faisal, Niraj Rai, Prabhat Poudel, Madeeha Subhan Waleed, Jonathan Quinonez, Samir Ruxmohan & Esha Jain. (2023) Investigating Edaravone Use for Management of Amyotrophic Lateral Sclerosis (ALS): A Narrative Review. Cureus.
Crossref
Crossref
Long-Fang Tu, Tian-Ze Zhang, Yang-Fan Zhou, Qing-Qing Zhou, Hai-Biao Gong, Lei Liang, Lin-Na Hai, Nan-Xin You, Yang Su, Yong-Jun Chen, Xu-Kai Mo, Chang-Zheng Shi, Liang-Ping Luo, Wan-Yang Sun, Wen-Jun Duan, Hiroshi Kurihara, Yi-Fang Li & Rong-Rong He. (2023) GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS. Journal of Advanced Research 43, pages 205-218.
Crossref
Crossref
Kartik Bhairu Khot, Gopika Gopan, Akshay Bandiwadekar & Jobin Jose. (2023) Current advancements related to phytobioactive compounds based liposomal delivery for neurodegenerative diseases. Ageing Research Reviews 83, pages 101806.
Crossref
Crossref
Pedro Soares, Catia Silva, Daniel Chavarria, Filomena S.G. Silva, Paulo J. Oliveira & Fernanda Borges. (2023) Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities. Ageing Research Reviews 83, pages 101790.
Crossref
Crossref
Luca Muzio, Alma Ghirelli, Federica Agosta & Gianvito Martino. 2023. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment
523
537
.
Mengxia Gao, Lingqun Zhu, Jingling Chang, Tianyu Cao, Lianying Song, Chunli Wen, Yi Chen, Yudi Zhuo & Fei Chen. (2022) Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis. Clinical Drug Investigation 43:1, pages 1-11.
Crossref
Crossref
Cinzia Volonté, Justin J. Yerbury & Ronald Sluyter. 2023. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
223
258
.
Jeffrey Cummings, Arturo Montes, Sana Kamboj & Jorge Fonseca Cacho. (2022) The role of basket trials in drug development for neurodegenerative disorders. Alzheimer's Research & Therapy 14:1.
Crossref
Crossref
Daniela Silva, Ruben Rocha, Ana Salomé Correia, Bárbara Mota, Maria Dulce Madeira, Nuno Vale & Armando Cardoso. (2022) Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study. Biomedicines 10:12, pages 3043.
Crossref
Crossref
Laura Moreno-Martinez, Llipsy Santiago, Miriam de la Torre, Ana Cristina Calvo, Julián Pardo & Rosario Osta. (2022) Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan. International Journal of Molecular Sciences 23:21, pages 13554.
Crossref
Crossref
Edoardo Parrella, Vanessa Porrini, Ilaria Scambi, Michele M. Gennari, Cristina Gussago, Oluwamolakun Bankole, Marina Benarese, Raffaella Mariotti & Marina Pizzi. (2022) Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Xiaoyun Lv & Xiaolan Lu. (2022) Significance of Edaravone Combined with Emotion Management Model in Promoting the Recovery Process and Improving Negative Psychology in Patients with Type 2 Diabetes Mellitus Combined with Stroke. BioMed Research International 2022, pages 1-8.
Crossref
Crossref
Maya Junghans, Felix John, Hilal Cihankaya, Daniel Schliebs, Konstanze F. Winklhofer, Verian Bader, Johann Matschke, Carsten Theiss & Veronika Matschke. (2022) ROS scavengers decrease γH2ax spots in motor neuronal nuclei of ALS model mice in vitro. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
Ghulam Mustafa, Muhammad Zia-ur-Rehman, Sajjad Hussain Sumrra, Muhammad Ashfaq, Wardha Zafar & Maryam Ashfaq. (2022) A critical review on recent trends on pharmacological applications of pyrazolone endowed derivatives. Journal of Molecular Structure 1262, pages 133044.
Crossref
Crossref
Li-Qin Zhao, Ankit Parikh, Yun-Xia Xiong, Qing-Yan Ye, Ying-Guo, Xin-Fu Zhou & Hai-Yun Luo. (2022) Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in Rats. Neurotoxicity Research 40:4, pages 995-1006.
Crossref
Crossref
Romain Regnault, Mostafa Kouach, Laurence Goossens, Xavier Thuru, Christian Bailly & Jean‐François Goossens. (2022) Mono‐ and bis‐edaravone adducts formed in the presence of vanillin in an aqueous solution. SEPARATION SCIENCE PLUS 5:7, pages 285-295.
Crossref
Crossref
Natascha Leleu-Chavain, Romain Regnault, Hania Ahouari, Raphaël Le Biannic, Mostafa Kouach, Frédérique Klupsch, Romain Magnez, Hervé Vezin, Xavier Thuru, Christian Bailly, Jean-François Goossens & Régis Millet. (2022) Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents. Molecules 27:10, pages 3316.
Crossref
Crossref
André D. J. Mckenzie, Taylor R. Garrett, Eryn L. Werry & Michael Kassiou. (2022)
Purinergic P2X
7
Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis
. ACS Chemical Neuroscience 13:10, pages 1479-1490.
Crossref
Crossref
Paola Ruffo, Sebastiano Cavallaro & Francesca Luisa Conforti. (2022) The Advent of Omics Sciences in Clinical Trials of Motor Neuron Diseases. Journal of Personalized Medicine 12:5, pages 758.
Crossref
Crossref
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, Youzhi Kuang, Brian K. Kwon & Vinod Labhasetwar. (2022) Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants 11:2, pages 408.
Crossref
Crossref
Tomoyuki Ueda, Taisei Ito, Masatoshi Inden, Hisaka Kurita, Akihito Yamamoto & Isao Hozumi. (2022) Stem Cells From Human Exfoliated Deciduous Teeth-Conditioned Medium (SHED-CM) is a Promising Treatment for Amyotrophic Lateral Sclerosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Simon Witzel, André Maier, Robert Steinbach, Julian Grosskreutz, Jan C. Koch, Anastasia Sarikidi, Susanne Petri, René Günther, Joachim Wolf, Andreas Hermann, Johannes Prudlo, Isabell Cordts, Paul Lingor, Wolfgang N. Löscher, Zacharias Kohl, Tim Hagenacker, Christian Ruckes, Birgit Koch, Susanne Spittel, Kornelia Günther, Sebastian Michels, Johannes Dorst, Thomas Meyer & Albert C. Ludolph. (2022) Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurology 79:2, pages 121.
Crossref
Crossref
Sun Joo Cha & Kiyoung Kim. (2022) Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection. Antioxidants 11:2, pages 195.
Crossref
Crossref
Jeffrey Cummings, Garam Lee, Pouyan Nahed, Mina Esmail Zadeh Nojoo Kambar, Kate Zhong, Jorge Fonseca & Kazem Taghva. (2022) Alzheimer's disease drug development pipeline: 2022. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Crossref
Silvia Bono, Marco Feligioni & Massimo Corbo. (2021) Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Molecular Neurodegeneration 16:1.
Crossref
Crossref
Zaynab Shakkour, Karl John Habashy, Moussa Berro, Samira Takkoush, Samar Abdelhady, Nadia Koleilat, Ali H. Eid, Kazem Zibara, Makram Obeid, Deborah Shear, Stefania Mondello, Kevin K. Wang & Firas Kobeissy. (2020) Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury. The Neuroscientist 27:6, pages 620-649.
Crossref
Crossref
C. Quarracino, M. Bendersky, R. Rey & G. E. Rodríguez. (2020) Logistics and safety of edaravone treatment for amyotrophic lateral sclerosis: experience in Argentina. Acta Neurologica Belgica 121:6, pages 1519-1523.
Crossref
Crossref
Sally Kelliny, Jing Xiong, Larisa Bobrovskaya & Xin-Fu Zhou. (2021) Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia. Neurotoxicity Research 39:6, pages 1689-1707.
Crossref
Crossref
Antonietta Tarallo, Carla Damiano, Sandra Strollo, Nadia Minopoli, Alessia Indrieri, Elena Polishchuk, Francesca Zappa, Edoardo Nusco, Simona Fecarotta, Caterina Porto, Marcella Coletta, Roberta Iacono, Marco Moracci, Roman Polishchuk, Diego Luis Medina, Paola Imbimbo, Daria Maria Monti, Maria Antonietta De Matteis & Giancarlo Parenti. (2021) Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease. EMBO Molecular Medicine 13:11.
Crossref
Crossref
Hideki Houzen, Takahiro Kano, Kazuhiro Horiuchi, Masahiro Wakita, Azusa Nagai & Ichiro Yabe. (2021) Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan. Pharmaceuticals 14:8, pages 705.
Crossref
Crossref
Nunzio Vicario, Federica M. Spitale, Daniele Tibullo, Cesarina Giallongo, Angela M. Amorini, Grazia Scandura, Graziana Spoto, Miriam W. Saab, Simona D’Aprile, Cristiana Alberghina, Renata Mangione, Joshua D. Bernstock, Cirino Botta, Massimo Gulisano, Emanuele Buratti, Giampiero Leanza, Robert Zorec, Michele Vecchio, Michelino Di Rosa, Giovanni Li Volti, Giuseppe Lazzarino, Rosalba Parenti & Rosario Gulino. (2021) Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing. Cell Death & Disease 12:7.
Crossref
Crossref
Qinqin Zhao, Bei Zheng, Pinpin Feng & Xiang Li. (2021) A Study to Decipher the Potential Effects of Butylphthalide against Central Nervous System Diseases Based on Network Pharmacology and Molecular Docking Integration Strategy. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-13.
Crossref
Crossref
Zaynab Shakkour, Hawraa Issa, Helene Ismail, Ohanes Ashekyan, Karl John Habashy, Leila Nasrallah, Hussam Jourdi, Eva Hamade, Stefania Mondello, Mirna Sabra, Kazem Zibara & Firas Kobeissy. (2021) Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury. Current Medicinal Chemistry 28:12, pages 2369-2391.
Crossref
Crossref
Falguni Baidya, Mariya Bohra, Aishika Datta, Deepaneeta Sarmah, Birva Shah, Priya Jagtap, Swapnil Raut, Ankan Sarkar, Upasna Singh, Kiran Kalia, Anupom Borah, Xin Wang, Kunjan R. Dave, Dileep R. Yavagal & Pallab Bhattacharya. (2020) Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases. Immunology 162:2, pages 160-178.
Crossref
Crossref
Robin Warner. 2021. Neurodegenerative Diseases - Molecular Mechanisms and Current Therapeutic Approaches. Neurodegenerative Diseases - Molecular Mechanisms and Current Therapeutic Approaches.
Jang Woo Lee, Seong-Woong Kang & Won Ah Choi. (2021) Clinical Course of Amyotrophic Lateral Sclerosis according to Initial Symptoms: An Analysis of 500 Cases. Yonsei Medical Journal 62:4, pages 338.
Crossref
Crossref
Hidetoshi Shimizu, Shinsuke Inoue, Mai Endo, Yoshinobu Nakamaru, Kaori Yoshida, Tomoko Natori, Masae Kakubari, Makoto Akimoto & Kazuoki Kondo. (2020) A Randomized, Single‐Blind, Placebo‐Controlled, 3‐Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects. Clinical Pharmacology in Drug Development 10:1, pages 46-56.
Crossref
Crossref
Zhenzhen Xu, Jianxiang Jiang, Shengyuan Xu, Zunchun Xie, Pei He, Shishi Jiang & Renshi Xu. (2020) Nerve Growth Factor is a Potential Treated Target in Tg(SOD1*G93A)1Gur Mice. Cellular and Molecular Neurobiology.
Crossref
Crossref
Luke McAlary, Yee Lian Chew, Jeremy Stephen Lum, Nicholas John Geraghty, Justin John Yerbury & Neil R. Cashman. (2020) Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Helene Ismail, Zaynab Shakkour, Maha Tabet, Samar Abdelhady, Abir Kobaisi, Reem Abedi, Leila Nasrallah, Gianfranco Pintus, Yusra Al-Dhaheri, Stefania Mondello, Riyad El-Khoury, Ali H. Eid, Firas Kobeissy & Johnny Salameh. (2020) Traumatic Brain Injury: Oxidative Stress and Novel Anti-Oxidants Such as Mitoquinone and Edaravone. Antioxidants 9:10, pages 943.
Crossref
Crossref
Ana Paula de Araújo Boleti, Taylla Michelle de Oliveira Flores, Susana Elisa Moreno, Lilian dos Anjos, Márcia Renata Mortari & Ludovico Migliolo. (2020) Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies. Neurochemistry International 136, pages 104714.
Crossref
Crossref
Humberto Foyaca Sibat & Lourdes de Fátima Ibañez Valdés. 2020. Novel Aspects on Motor Neuron Disease. Novel Aspects on Motor Neuron Disease.
I Nyoman Semadi, Kelvin Setiawan & Hendry Irawan. (2020) Clinical profile and laboratory finding of diabetic foot ulcers from tertiary hospitals in Bali. Polish Annals of Medicine.
Crossref
Crossref
Natalia Nowicka, Jakub Juranek, Judyta K. Juranek & Joanna Wojtkiewicz. (2019) Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 20:11, pages 2616.
Crossref
Crossref